Riccardo Canevari

Chief Executive Officer RadioPharm Theranostics

• Radiopharm Theranostics CEO since 2021
• Previously, Chief Commercial Officer of Novartis Company Advanced Accelerator Applications S.A.
• Lead for Lutathera in-market growth strategy and Pluvicto launch strategy
• Senior Vice President & Global Head, Breast Cancer Franchise, for Novartis Oncology
• Lead for CDK4/6 (Kisqali) global launch in HR+ Breast Cancer

Seminars

Wednesday 24th February 2027
Validating Targets in the Brain: Using Imaging to Build Confidence in Therapeutic Potential
1:30 pm
  • Use brain metastases as a clinical case study to understand target accessibility, engagement, and biodistribution within the challenging brain environment
  • Leverage clinical imaging to determine whether a targeting agent can reach and sufficiently accumulate within brain lesions
  • Translate lessons from imaging into target-validation criteria for therapeutic development, while accounting for the different requirements of imaging and RLT

Novel Target

Riccardo Canevari, Speaker at 3rd TRP Target Selection & Drug Design Summit